We are live on
!
Find out more
First Manhattan Portfolio holdings
AUM
$36.1B
1-Year Est. Return
11.5%
This Fund
S&P 500
This Quarter
Est. Return
+2%
1 Year Est. Return
+11.5%
3 Year Est. Return
+74.65%
5 Year Est. Return
+103.66%
10 Year Est. Return
+354.63%
AUM
$15.2B
AUM Growth
+$50.6M
(+0.33%)
Cap. Flow
-$162M
Cap. Flow
% of AUM
-1.07%
Top 10 Holdings %
Top 10 Hldgs %
39.77%
Holding
1,536
New
117
Increased
196
Reduced
365
Closed
83
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$64.7M |
| 2 |
Oracle
ORCL
|
+$59M |
| 3 |
Leidos
LDOS
|
+$54.6M |
| 4 |
LO
LORILLARD INC COM STK
LO
|
+$37.3M |
| 5 |
DTV
DIRECTV COM STK (DE)
DTV
|
+$26.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ameren
AEE
|
+$53.3M |
| 2 |
Berkshire Hathaway Class A
BRK.A
|
+$53.2M |
| 3 |
FRX
FOREST LABORATORIES INC
FRX
|
+$32.6M |
| 4 |
TYC
TYCO INTL PLC COM SHS (IRL)
TYC
|
+$31.4M |
| 5 |
Allison Transmission
ALSN
|
+$27M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 39.01% |
| 2 | Healthcare | 11.19% |
| 3 | Industrials | 8.55% |
| 4 | Technology | 7.57% |
| 5 | Energy | 6.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Robert Half
RHI
$3.71B
| $2.91M | 0.02% |
69,378
-34,389
| -33% | -$1.42M |
|
302
Emerson Electric
EMR
$83.1B
| $2.86M | 0.02% |
42,757
+929
| +2% | +$61.1K |
|
303
Hershey
HSY
$35.3B
| $2.85M | 0.02% |
27,324
| – | – |
|
|
Y
304
DELISTED
Alleghany Corp
Y
| $2.82M | 0.02% |
6,928
| – | – |
|
|
BCR
305
DELISTED
CR Bard Inc.
BCR
| $2.79M | 0.02% |
18,859
-1,300
| -6% | -$180K |
|
|
IBCA
306
DELISTED
INTERVEST BANCSHARES CORP COM
IBCA
| $2.76M | 0.02% |
370,349
| – | – |
|
|
FLY
307
DELISTED
Fly Leasing Limited
FLY
| $2.74M | 0.02% |
182,900
| – | – |
|
308
Analog Devices
ADI
$181B
| $2.7M | 0.02% |
50,850
-1,100
| -2% | -$55.5K |
|
309
Vodafone
VOD
$35B
| $2.67M | 0.02% |
72,678
-109,591
| -60% | -$4.22M |
|
|
VIA
310
DELISTED
Viacom Inc. Class A
VIA
| $2.67M | 0.02% |
31,350
| – | – |
|
311
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
$4.67B
| $2.59M | 0.02% |
2,207
+444
| +25% | +$516K |
|
|
LINE
312
DELISTED
LINN ENERGY LLC COM UTS REP LTD LIABILITY CO INTS
LINE
| $2.56M | 0.02% |
90,500
-17,150
| -16% | -$541K |
|
313
Newmont
NEM
$100B
| $2.52M | 0.02% |
107,561
| – | – |
|
|
SPHS
314
DELISTED
Sophiris Bio, Inc.
SPHS
| $2.5M | 0.02% |
751,842
-248,658
| -25% | -$974K |
|
315
SPDR Gold Trust
GLD
$131B
| $2.44M | 0.02% |
19,773
-100
| -0.5% | -$12.5K |
|
|
BFS
316
Saul Centers
BFS
$876M
| $2.44M | 0.02% |
51,451
-2,900
| -5% | -$135K |
|
317
Johnson Controls International
JCI
$87.6B
| $2.43M | 0.02% |
48,978
+722
| +1% | +$36.6K |
|
|
SYA
318
DELISTED
SYMETRA FINANCIAL CORPORATION COMMON STOCK
SYA
| $2.38M | 0.02% |
120,000
| – | – |
|
|
NVO
319
Novo Nordisk
NVO
$216B
| $2.34M | 0.02% |
102,350
| – | – |
|
320
Leggett & Platt
LEG
$1.53B
| $2.28M | 0.02% |
69,775
+500
| +0.7% | +$15.5K |
|
|
HES
321
DELISTED
Hess
HES
| $2.19M | 0.01% |
26,403
| – | – |
|
|
SJT
322
San Juan Basin Royalty Trust
SJT
$118M
| $2.19M | 0.01% |
123,961
+9
| +0% | +$156 |
|
323
Equity Residential
EQR
$25.5B
| $2.17M | 0.01% |
37,448
| – | – |
|
324
Air Products & Chemicals
APD
$66.1B
| $2.15M | 0.01% |
19,513
+540
| +3% | +$57.3K |
|
325
Costco
COST
$413B
| $2.14M | 0.01% |
19,128
| – | – |
|
Similar funds
SAM
First Manhattan's Q1 2014 Portfolio in Review
As of Q1 2014, First Manhattan held 1,536 positions worth $15.2B, up 0.33% from $15.1B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
First Manhattan's Q1 2014 filing shows 117 new, 196 increased, 365 reduced and 83 closed positions. Its largest new stake was Leidos: 1,228,013 shares worth $43.4M. The largest sale was Ameren, an estimated $53.3M.
By sector, the portfolio is most concentrated in Financials at 39% of assets, up from 38% a quarter earlier, followed by Healthcare and Industrials.
- First Manhattan's largest Q1 2014 buy was Leidos: 1,228,013 shares worth $43.4M.
- First Manhattan added most to Citigroup in Q1 2014, an estimated $64.7M increase.
- First Manhattan's biggest Q1 2014 reduction was Ameren, cutting an estimated $53.3M.
- First Manhattan fully exited Aegerion Pharmaceuticals in Q1 2014, selling an estimated $18.7M.
- First Manhattan's ten largest holdings make up 40% of its $15.2B portfolio in Q1 2014.
- First Manhattan opened 117 new positions and closed 83 in Q1 2014.
- First Manhattan's portfolio value rose 0.33% quarter-over-quarter to $15.2B.
Based on First Manhattan's 13F filing for Q1 2014, filed 16 May 2014.